Endotoxemia-related acute kidney injury in transgenic mice with endothelial overexpression of GTP cyclohydrolase-1.

Endotoxemia-related acute kidney injury in transgenic mice with endothelial overexpression of GTP cyclohydrolase-1. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Endotoxemia-related acute kidney injury in transgenic mice with endothelial overexpression of GTP cyclohydrolase-1. Abstract Text:

Wei Wang,Einath Zolty,Sandor Falk,Sandra Summer,Zhu Zhou,Patricia Gengaro,Sarah Faubel,Nicholas Alp,Keith Channon,Robert Schrier,

Endotoxin-related acute kidney injury has been shown to profoundly induce nitric oxide (NO), which activates sympathetic and renin-angiotensin system, resulting in renal vasoconstriction. While vascular muscle cells are known to upregulate inducible NO synthase (iNOS), less is known about the endothelium as a source of NO during endotoxemia. Studies were, therefore, undertaken both in vitro in mouse microvascular endothelial cells and in vivo in transgenic mice with overexpression of endothelial GTP cyclohydrolase, the rate-limiting enzyme for tetrahydrobiopterin, a cofactor for NO synthase. LPS significantly induced endothelial cell iNOS expression and NO concentration in the culture media, with no change in endothelial NO synthase expression. GTP cyclohydrolase-1 transgenic (Tg) mice demonstrated a significant increase in baseline urine NO-to-creatinine ratio and a more significant increase in renal iNOS expression and serum NO levels with LPS treatment compared with the wild-type (WT) mice. Glomerular filtration rate and renal blood flow decreased significantly in Tg mice with 1.0 mg/kg LPS, while no changes were observed in WT with the same dose of LPS. Serum IL-6 levels were significantly higher in Tg compared with WT mice during endotoxemia. The antioxidant tempol improved the glomerular filtration rate in the Tg mice. Thus endothelium can be an important source of iNOS and serum NO concentration during endotoxemia, thereby increasing the sensitivity to AKI. Reactive oxygen species appear to be involved in this acute renal injury in Tg mice during endotoxemia.

Endotoxemia-related acute kidney injury in transgenic mice with endothelial overexpression of GTP cyclohydrolase-1. Publishing Authors By Initials

W Wang,E Zolty,S Falk,S Summer,Z Zhou,P Gengaro,S Faubel,N Alp,K Channon,R Schrier,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Endotoxemia-related acute kidney injury in transgenic mice with endothelial overexpression of GTP cyclohydrolase-1. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: American journal of physiology. Renal physiology

VOLUME: 294

Page Numbers: F571-6

Journal Abbreviation: Am. J. Physiol. Renal Physiol.

ISSN: 0363-6127

DAY: 2

MONTH: 01

YEAR: 2008

Endotoxemia-related acute kidney injury in transgenic mice with endothelial overexpression of GTP cyclohydrolase-1. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 100901990

Endotoxemia-related acute kidney injury in transgenic mice with endothelial overexpression of GTP cyclohydrolase-1. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Endotoxemia-related acute kidney injury in transgenic mice with endothelial overexpression of GTP cyclohydrolase-1. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Endotoxemia-related acute kidney injury in transgenic mice with endothelial overexpression of GTP cyclohydrolase-1.

AFFILIATION: Dept. of Medicine, Univ. of Colorado School of Medicine, 4200 E. 9th Ave., Box B-281, Denver, CO 80262-0001. robert.schrier@uchsc.edu).

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Am J Physiol Renal Physiol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Endotoxemia-related acute kidney injury in transgenic mice with endothelial overexpression of GTP cyclohydrolase-1 Related Publications

• Analysis of N-ras mutations in human cutaneous melanoma: tumor heterogeneity detected by polymerase chain reaction/single-stranded conformation polymorphism analysis.
• Aquaporin-related disorders of water homeostasis.
• Autosomal-dominant polycystic kidney disease in infancy and childhood: progression and outcome.
• Calcium channel blockers: protective effects in ischemic acute renal failure.
• Decreased effective blood volume in edematous disorders: what does this mean?
• Developments in the management of autosomal dominant polycystic kidney disease.
• Efficient Synthetic Access to a New Family of Highly Potent Bryostatin Analogues via a Prins-Driven Macrocyclization Strategy.
• Endotoxemia-related acute kidney injury in transgenic mice with endothelial overexpression of GTP cyclohydrolase-1.
• Further in vivo evidence for antagonist-to-antidiuretic action of arginine vasopressin.
• Hyperosmolality in vivo upregulates aquaporin 2 water channel and Na-K-2Cl co-transporter in Brattleboro rats.
• Induced alterations in calcium uptake rate in normoxic rate proximal tubules.
• Molecular mechanisms of antidiuretic effect of oxytocin.
• Molecular mechanisms of clinical concentrating and diluting disorders.
• Nepafenac-associated corneal melt.
• Nitric oxide synthase inhibition and acute renal ischemia: effect on systemic hemodynamics and mortality.
• Polyuria of thyrotoxicosis: downregulation of aquaporin water channels and increased solute excretion.
• Potential pharmacological interventions in polycystic kidney disease.
• Prostacyclin in endotoxemia-induced acute kidney injury: cyclooxygenase inhibition and renal prostacyclin synthase transgenic mice.
• Relationship between urinary albumin excretion and left ventricular mass with mortality in patients with type 2 diabetes.
• Role of AQP1 in endotoxemia-induced acute kidney injury.
• Sarcoidosis of the nervous system.
• The role of calcium in the pathogenesis of acute renal failure.
• The role of the calcium-dependent enzymes nitric oxide synthase and calpain in hypoxia-induced proximal tubule injury.
• The sea within us: disorders of body water homeostasis.
• Therapy of acute myelocytic leukemia. Daunomycin contrasted with a combination of cytosine arabinoside and 6-thioguanine.
• Tribromethanol (Avertin).
• Variation in age at ESRD in autosomal dominant polycystic kidney disease.
• Vascular effects of arginine vasopressin, angiotensin II, and norepinephrine in adrenal insufficiency.
• Vascular effects of arginine-vasopressin, angiotensin and noradrenaline in adrenal insufficiency.
• Vasopressin and aquaporin 2 in clinical disorders of water homeostasis.